Presentation and early detection of post‐transplant lymphoproliferative disorder after solid organ transplantation

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transplant International

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2006.00416.xPMID 17291214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunosurveillance, Immunodeficiencies and Lymphoproliferations

  2012cited by this paper
• Epstein-Barr Virus–Associated Posttransplantation Lymphoproliferative Disorder Following Lung Transplantation Is More Commonly of Host Origin

  2009cited by this paper
• Post-transplant lymphoproliferative disease

  2009cited by this paper
• Epstein-Barr Virus–DNA Load Monitoring Late After Lung Transplantation: A Surrogate Marker of the Degree of Immunosuppression and a Safe Guide to Reduce Immunosuppression

  2007cited by this paper
• Use of cytokine polymorphisms and Epstein–Barr virus viral load to predict development of post‐transplant lymphoproliferative disorder in paediatric liver transplant recipients

  2006cited by this paper
• TREATMENT OF SOLID ORGAN TRANSPLANT RECIPIENTS WITH AUTOLOGOUS EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTL). Running title: T cell therapy for PTLD in Solid organ transplant recipients

  2006cited by this paper
• PTLD Visualization by FDG‐PET: Improved Detection of Extranodal Localizations

  2006cited by this paper
• Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

  2006cited by this paper
• Polyomavirus‐associated nephropathy: update on BK virus‐specific immunity

  2006cited by this paper
• A Randomized Trial of Ganciclovir versus Ganciclovir Plus Immune Globulin for Prophylaxis Against Epstein-Barr Virus Related Posttransplant Lymphoproliferative Disorder

  2006cited by this paper
• The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.

  2006cited by this paper
• CMV‐IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients

  2006cited by this paper
• Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

  2006cited by this paper
• Treatment of PTLD with Rituximab or Chemotherapy

  2006cited by this paper
• 18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

  2006cited by this paper
• Post-transplant lymphoproliferative disease: association with induction therapy?

  2006cited by this paper
• Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.

  2006cited by this paper
• Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high‐risk for EBV infection

  2006cited by this paper
• Management of patients with post‐transplant lymphoproliferative disorder: the role of rituximab

  2006cited by this paper
• Differences between Early and Late Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Patients: Are They Two Different Diseases?

  2005cited by this paper
• Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients

  2005cited by this paper
• FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation

  2005cited by this paper
• Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

  2005cited by this paper
• HLA matching and posttransplant lymphoproliferative disease after lung transplantation.

  2005cited by this paper
• Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients

  2005cited by this paper
• Simultaneous Development of Lymphoma in Recipients of Renal Transplants from a Single Donor: Donor Origin Confirmed by Human Leukocyte Antigen Staining and Microsatellite Analysis

  2005cited by this paper
• EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.

  2005cited by this paper
• Early onset post‐transplant lymphoproliferative disease is associated with allograft localization

  2005influential reference
• Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.

  2005cited by this paper
• Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

  2005cited by this paper
• Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohort

  2005cited by this paper
• IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.

  2005cited by this paper
• Sinonasal Posttransplant Lymphoproliferative Disorder in Pediatric Lung Transplant Patients

  2005cited by this paper
• Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.

  2005cited by this paper
• Treatment of EBV‐Related Post‐Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV‐Specific T Cells

  2005cited by this paper
• Induction of pre‐transplant Epstein–Barr virus (EBV) infection by donor blood transfusion in EBV–seronegative recipients may reduce risk of post‐transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases

  2005cited by this paper
• HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical

  2005cited by this paper
• Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

  2005cited by this paper
• Rituximab (Chimeric Anti-CD20 Antibody) for Posttransplant Lymphoproliferative Disorder after Solid Organ Transplantation in Adults: Long-Term Experience from a Single Center

  2005cited by this paper
• Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients

  2005cited by this paper
• Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era

  2005cited by this paper
• Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression

  2005cited by this paper
• Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

  2005cited by this paper
• EBV Kidney Allograft Infection: Possible Relationship with a Peri‐Graft Localization of PTLD

  2004cited by this paper
• Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

  2004influential reference
• Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.

  2004cited by this paper
• Immunosuppression and the Risk of Post‐Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients

  2004cited by this paper
• Literature abstracts

  2004cited by this paper
• Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real‐time PCR light cycler

  2004cited by this paper
• Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.

  2004cited by this paper
• Prompt versus preemptive intervention for EBV lymphoproliferative disease.

  2004cited by this paper
• Positron Emission Tomography With Fluoro-2-deoxy-D-glucose (FDG-PET) in the Staging of Post Transplant Lymphoproliferative Disorder in Lung Transplant Recipients

  2004cited by this paper
• Epstein-Barr Virus Primary Mismatching and HLA Matching: Key Risk Factors for Post Lung Transplant Lymphoproliferative Disease

  2004cited by this paper
• CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES

  2004cited by this paper
• Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.

  2003cited by this paper
• Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients1

  2003cited by this paper
• Epstein-Barr virus-associated cancers: aetiology and treatment.

  2003cited by this paper
• Lymphoproliferative disorders in Oxford renal transplant recipients

  2003cited by this paper
• Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

  2003cited by this paper
• Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.

  2003cited by this paper
• Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1

  2003cited by this paper
• Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR

  2003cited by this paper
• Posttransplant lymphoproliferative disorders presenting at sites of previous surgical intervention.

  2003cited by this paper
• Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching1

  2003cited by this paper
• Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.

  2003cited by this paper
• Epstein–Barr virus (EBV) load and interleukin‐10 in EBV‐positive and EBV‐negative post‐transplant lymphoproliferative disorders

  2003cited by this paper
• Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

  2003cited by this paper
• Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.1

  2003cited by this paper
• Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.

  2003cited by this paper
• Limitations of EBV–PCR monitoring to detect EBV associated post‐transplant lymphoproliferative disorder

  2003cited by this paper
• A single-centre experience of post-renal transplant lymphoproliferative disorder

  2003cited by this paper
• Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

  2003cited by this paper
• Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

  2003cited by this paper
• Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients

  2002cited by this paper
• Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations.

  2002cited by this paper
• Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.

  2002cited by this paper
• Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

  2002cited by this paper
• Use of EBV PCR for the Diagnosis and Monitoring of Post‐Transplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Patients

  2002cited by this paper
• Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.

  2002cited by this paper
• Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction12

  2002cited by this paper
• Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series.

  2002cited by this paper
• Mycophenolate, tacrolimus and post‐transplant lymphoproliferative disorder: A report of the North American Pediatric Renal Transplant Cooperative Study

  2002cited by this paper
• Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management

  2002cited by this paper
• Identification of early antigen BZLF1/ZEBRA protein of Epstein–Barr virus can predict the effectiveness of antiviral treatment in patients with post‐transplant lymphoproliferative disease

  2002cited by this paper
• Role of Epstein-Barr Virus DNA Load Monitoring in Prevention and Early Detection of Post-transplant Lymphoproliferative Disease

  2002cited by this paper
• Lymphomas occurring late after solid-organ transplantation: Influence of treatment on the clinical outcome

  2002cited by this paper
• Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation.

  2002cited by this paper
• Posttransplant Lymphoproliferative Disorders in Lung Transplant Patients: The Cleveland Clinic Experience

  2002cited by this paper
• REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1

  2001cited by this paper
• Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders

  2001cited by this paper
• Lymphoproliferative disorders after liver transplantation: imaging features

  2001cited by this paper
• Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients.

  2001cited by this paper
• Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.

  2001cited by this paper
• Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.

  2001cited by this paper
• The Epstein–Barr virus and post‐transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis

  2001cited by this paper
• Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen

  2001cited by this paper
• The diverse pathology of post‐transplant lymphoproliferative disorders: the importance of a standardized approach

  2001influential reference
• PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

  2001cited by this paper
• Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

  2001cited by this paper
• Epstein–Barr virus load monitoring: its role in the prevention and management of post‐transplant lymphoproliferative disease

  2001cited by this paper

• Predictors of Posttransplant Lymphoproliferative Disease in Pediatric Patients

  2025cites this paper
• Oncological Complications of Liver Transplantation: A Narrative Review on De Novo and Donor-Transmitted Cancers

  2025cites this paper
• Epigenetic Activation of the EBV Protein Kinase Determines Antiviral Drug Response in Central Nervous System Lymphoma

  2024cites this paper
• A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques

  2024cites this paper
• A pediatric case series of catastrophic gastrointestinal complications of posttransplant lymphoproliferative disease with increasing incidence, high association with coronavirus disease 2019, higher mortality, and a plea for early endoscopy to prevent late fatal outcome

  2023cites this paper
• EBV-encoded miRNAs BHRF1-1 and BART2-5p aggravate post- transplant lymphoproliferative disorder via LZTS2-PI3K-AKT axis.

  2023cites this paper
• Diagnostic and management roles of FDG PET/CT imaging in post‐transplant lympho‐proliferation in pediatric heart transplantation

  2023cites this paper
• Screening and Management of PTLD

  2023cites this paper
• Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients.

  2023cites this paper
• Ultrasound of pancreatic transplant complications: a primer for radiologists.

  2023cites this paper
• Enfermedadlinfoproliferativa difusa postrasplanterenal: Estudiolonguitudinalde 21.546 receptores durante 2 decadas en España

  2022cites this paper
• Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,

  2022cites this paper
• High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD

  2022cites this paper
• A Rare Case of Jejunal Perforation due to Post-transplant Lymphoproliferative Disease 27 Years after Liver Transplant

  2021cites this paper
• Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria

  2021cites this paper
• PET-CT in Infection and Inflammation

  2021cites this paper
• An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient

  2021cites this paper
• Other less Frequent Pancreatic Tumors

  2021cites this paper
• The impact of chronic Epstein–Barr virus infection on the liver graft of pediatric liver transplant recipients: A retrospective observational study

  2021cites this paper
• Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy

  2021cites this paper
• Case 16990 A suspicious spleen: PostTransplant Lymphoproliferative Disorder.

  2021cites this paper
• Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes.

  2020cites this paper
• Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients.

  2020cites this paper
• Primary Care of the Solid Organ Transplant Recipient

  2020cites this paper
• PET-CT in the Organ Transplantation

  2020cites this paper
• Cancer Risk in the Adult Solid Organ Transplant Recipient

  2020cites this paper
• Roles of F-18-Fluoro-2-Deoxy-Glucose PET/Computed Tomography Scans in the Management of Post-Transplant Lymphoproliferative Disease in Pediatric Patient.

  2020cites this paper
• Epstein‐Barr viral load monitoring for diagnosing post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients

  2020cites this paper
• Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder

  2019cites this paper
• Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disease

  2019cites this paper
• A Rare Cause of Respiratory Distress in a Toddler

  2019cites this paper
• Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield

  2019cites this paper
• Imaging complications of liver transplantation: a multimodality pictorial review

  2019cites this paper
• De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature

  2019cites this paper
• A review of adenotonsillar hypertrophy and adenotonsillectomy in children after solid organ transplantation.

  2018cites this paper
• Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-α-Antikörpern bei chronisch-entzündlichen Darmerkrankungen

  2018cites this paper
• Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.

  2018influential citation
• Late Posttransplant Lymphoproliferative Disease: Report of a Rare Case and Role of Positron Emission Tomography-computed Tomography

  2018influential citation
• National survey of de novo malignancy after solid organ transplantation in Japan

  2018cites this paper
• Herpesviruses (Herpesviridae)

  2018cites this paper
• Hepatitis C virus infection in patients with chronic kidney disease and kidney transplantation: an update

  2018cites this paper
• Contemporary Kidney Transplantation

  2018cites this paper
• Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis

  2017cites this paper
• Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach

  2017cites this paper
• Post-transplant lymphoproliferative disease in liver transplant recipients.

  2017cites this paper
• Clinical Utility of Epstein-Barr Viral Load Assay to Diagnose Posttransplant Lymphoproliferative Disorders in Pediatric Heart Transplant Recipients

  2017cites this paper
• Imaging in pediatric renal transplantation

  2017cites this paper
• Post-transplant lymphoproliferative disorder after kidney transplantation

  2017cites this paper
• Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

  2017cites this paper
• Síndrome linfoproliferativo en el trasplante hepático

  2017cites this paper
• Radiology of Kidney Transplantation

  2017cites this paper
• Viral Infections After Intestinal Transplantation

  2017cites this paper
• Epstein-Barr virus and renal transplantation.

  2017cites this paper
• Nuclear medicine techniques in transplantation

  2017cites this paper
• 18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation

  2017cites this paper
• Imaging features of haematological malignancies of kidneys.

  2016cites this paper
• Pathologie der transplantierten Niere

  2016cites this paper
• An unusual endoscopic ultrasound diagnosis in kidney-transplant patient

  2016cites this paper
• De novo malignancy after lung transplantation in Japan

  2016cites this paper
• Rapid and Early Diagnosis of Posttransplant Lymphoproliferative Disease Using Cross-Sectional Nuclear Medicine Imaging and Laparoscopic Lymph Node Biopsy: A Report of 2 Cases.

  2016cites this paper
• A Case of Post-Transplant Lymphoproliferative Disorder (PTLD) Following Renal Transplantation That was Difficult to Distinguish from Hepatic Sarcoma.

  2016cites this paper
• Role of diffusion weighted imaging in diagnosis of post transplant lymphoproliferative disorders: Case reports and review of literature

  2016cites this paper
• The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection

  2016cites this paper
• Hepatitis C and kidney disease: A narrative review

  2016cites this paper
• Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management.

  2016cites this paper
• Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors

  2015cites this paper
• Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship

  2015influential citation
• Metastatic Neuroendocrine Tumour in a Renal Transplant Recipient: Dual-Tracer PET-CT with 18F-FDG and 68Ga-DOTANOC in This Rare Setting

  2015cites this paper
• Cancer Epigenetics

  2015cites this paper
• Hematologic malignancies of the liver: spectrum of disease.

  2015cites this paper
• Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer

  2015cites this paper
• Cancer-associated infectious agents and epigenetic regulation.

  2015cites this paper
• Pulmonary nodules and masses in lung transplant recipients: clinical and CT findings

  2014cites this paper
• Advances in the management of viral infections.

  2014cites this paper
• Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient

  2014cites this paper
• 18F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder

  2014cites this paper
• Cáncer de piel en pacientes con trasplante de órgano sólido

  2014influential citation
• Anesthetic considerations for an adult heart transplant recipient undergoing noncardiac surgery: a case report.

  2014cites this paper
• Prevention and treatment for Epstein-Barr virus infection and related cancers.

  2014cites this paper
• Hematologic malignancies of the pancreas

  2014cites this paper
• Post-Transplantive Disorder of the Pancreas, Report of a Case Localized to the Pancreatic Head

  2014cites this paper
• Multiple Infections and Cancer: Implications in Epidemiology

  2014cites this paper
• Comparative analysis of post‐transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation

  2014cites this paper
• Opportunistic viral infections in intestinal transplantation

  2013cites this paper
• Environmental and genetic risk factors for post-transplant lymphoproliferative disease :

  2013cites this paper
• Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab

  2013cites this paper
• Screening of de novo tumors after liver transplantation

  2012cites this paper
• Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience

  2012cites this paper
• Post‐transplantation lymphoproliferative disorder in pediatric kidney‐transplant recipients – A national study

  2012cites this paper
• Diagnostic role of whole-body [18F]-FDG positron emission tomography in patients with symptoms suspicious for malignancy after heart transplantation.

  2012cites this paper
• An unusual manifestation of post‐transplant lymphoproliferative disorder in the lip after pediatric heart transplantation

  2012influential citation
• Viremia after Lung Transplant: A Cohort Study on Risk Factors and Symptoms Associated with Detection of Epstein-Barr Virus

  2012cites this paper
• Malignancy Following Renal Transplantation

  2012cites this paper
• Lymphocytic Interstitial Pneumonia and Other Benign Lymphoid Disorders

  2012cites this paper
• Posttransplant lymphoproliferative disorder presenting as a nonhealing extraction socket: a case report and review of the literature.

  2012cites this paper
• A Pictorial Review of Spectrum of Radiologic Finding in PTLD

  2012influential citation
• Diseases Transmitted by Transplantation of Tissue and Cell Allografts

  2012cites this paper
• New concepts and best practices for management of pre- and post-transplantation cancer.

  2012cites this paper
• Acute Viral Syndromes

  2011cites this paper
• Children with Intestinal Failure and Complications from Visceral Transplant

  2011cites this paper